Aligos Therapeutics's market cap is currently $60.22M. The company's EPS TTM is $-1.53; its P/E ratio is ―; Aligos Therapeutics is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-1.90. See an overview of income statement, balance sheet, and cash flow financials.
